A novel series of matrix metalloproteinase (MMP) inhibitors is described. Incorporation of a terminal alpha-mercaptoketone or alpha-mercaptoalcohol in the zinc binding domain of a series of inhibitors led to compounds exhibiting low nanomolar activity against collagenase-1 (MMP-1), stromelysin (MMP-3), and gelatinase-B (MMP-9).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(98)00185-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!